Clinical Trial: High-dose Erythropoietin for Asphyxia and Encephalopathy

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: High-dose Erythropoietin for Asphyxia and Encephalopathy

Brief Summary: Hypoxic-ischemic encephalopathy (HIE) occurs when a baby gets reduced blood flow and oxygen to the brain near the time of birth. This results in death or neurologic disabilities including cerebral palsy and cognitive impairment in up to half of affected infants. This clinical trial will determine if the drug erythropoietin (Epo) added to hypothermia (usual therapy) will improve outcomes for infants suffering from HIE.